×
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
LON:SALV

SalvaRx Group Share Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
4.50
4.50
52-Week Range
N/A
Volume
50,758 shs
Average Volume
50,758 shs
Market Capitalization
£1.65 million
P/E Ratio
0.03
Dividend Yield
N/A
Price Target
N/A

Receive SALV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SalvaRx Group and its competitors with MarketBeat's FREE daily newsletter.

SALV Stock Forecast (MarketRank)

Overall MarketRank

1.21 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

About SalvaRx Group

SalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man.

SALV Stock News Headlines

SalvaRx Group plc (LON:SALV): Are Analysts Optimistic?
Salvarx Group Plc Share Chat
SalvaRx Turns To Interim Profit, Evaluating Takeover Opportunities
Salvarx Group Plc Share Chat (SALV)
Portage Announces Change of CEO
Shareholders approve Acquisition of SalvaRx Limited
See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£64.50 million
Book Value
GBX 15.40 per share

Miscellaneous

Free Float
N/A
Market Cap
£1.65 million
Optionable
Not Optionable
Beta
N/A














SalvaRx Group Frequently Asked Questions

Who are SalvaRx Group's key executives?

SalvaRx Group's management team includes the following people:
  • Mr. Denham Hervey Newall Eke, CFO & Director (Age 67)

What other stocks do shareholders of SalvaRx Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SalvaRx Group investors own include Premier African Minerals (PREM), Cradle Arc (CRA), Cora Gold (CORA), Big Sofa Technologies Group (BST), Bahamas Petroleum (BPC), Bacanora Lithium (BCN), AutoZone (AZO), Angus Energy (ANGS), Allergy Therapeutics (AGY) and AFR.L (AFR).

What is SalvaRx Group's stock symbol?

SalvaRx Group trades on the London Stock Exchange (LON) under the ticker symbol "SALV."

How do I buy shares of SalvaRx Group?

Shares of SALV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How much money does SalvaRx Group make?

SalvaRx Group (LON:SALV) has a market capitalization of £0.00 and generates £64.50 million in revenue each year.

How many employees does SalvaRx Group have?

SalvaRx Group employs 2 workers across the globe.

How can I contact SalvaRx Group?

SalvaRx Group's mailing address is Commerce House, 1 Bowring Road, RAMSEY, RAMSAY, IM8 2LQ, Isle of Man. The official website for SalvaRx Group is www.salvarx.io. The company can be reached via phone at +44-1624-811611.

This page (LON:SALV) was last updated on 6/30/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.